Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
2002518 citationsPamela J. Goodwin, Marguerite Ennis et al.Journal of Clinical Oncologyprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Warren Hartwick
Since
Specialization
Citations
This map shows the geographic impact of Warren Hartwick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Warren Hartwick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Warren Hartwick more than expected).
This network shows the impact of papers produced by Warren Hartwick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Warren Hartwick. The network helps show where Warren Hartwick may publish in the future.
Co-authorship network of co-authors of Warren Hartwick
This figure shows the co-authorship network connecting the top 25 collaborators of Warren Hartwick.
A scholar is included among the top collaborators of Warren Hartwick based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Warren Hartwick. Warren Hartwick is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
12 of 12 papers shown
1.
Goodwin, Pamela J., Marguerite Ennis, Kathleen I. Pritchard, et al.. (2002). Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study. Journal of Clinical Oncology. 20(1). 42–51.518 indexed citations breakdown →
Yousef, George M., Lianna Kyriakopoulou, Andreas Scorilas, et al.. (2001). Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.. PubMed. 61(21). 7811–8.89 indexed citations
Hartwick, Warren, et al.. (1998). Cyclin D1 gene amplification and protein expression in benign breast disease and breast carcinoma.. PubMed. 11(11). 1082–8.38 indexed citations
Runge, Martin, Martin Ganter, Warren Hartwick, et al.. (1996). [Demonstration of pneumonia in swine as a constant problem: culture and immunofluorescence microscopic studies of bronchioalveolar lavage (BAL) and serological findings].. PubMed. 109(3). 101–7.6 indexed citations
9.
Witterick, Ian, et al.. (1993). Incidence and types of non-palpable thyroid nodules in thyroids removed for palpable disease.. PubMed. 22(4). 294–300.6 indexed citations
10.
Fliss, Dan M., et al.. (1992). RESIDENT'S PAGE. Archives of Otolaryngology - Head and Neck Surgery. 118(8). 878–881.2 indexed citations
Urbanski, S. J., et al.. (1986). Mucosal changes associated with adenomatous colonic polyps.. PubMed. 124(1). 34–8.3 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.